• PDF: Delivered by email usually within 48 UK business hours.

Five Prime Therapeutics, Inc. - Pharmaceuticals & Healthcare
Deals and Alliances Profile

  • Publication Date:March 2012
  • Publisher:GlobalData
  • Product Type: Report
  • Pages:42

Five Prime Therapeutics, Inc. - Pharmaceuticals & Healthcare Deals and Alliances Profile

Summary

Five Prime Therapeutics, Inc. (FivePrime) is a privately held clinical stage biotechnology company. It is principally engaged in the discovery and development of protein and antibody therapeutics. The company's products are used in different therapy areas such as Oncology, Immunology, and Diabetes and Regenerative medicine. The company has entered into worldwide Oncology and Diabetes collaborative research and license agreement with Pfizer. In addition, Five Prime has discovery collaborations with Pfizer in the field of cancer and diabetes, Centocor in the field of pulmonary fibrosis and osteoarthritis, Boehringer Ingelheim in the field of rheumatoid arthritis and also with Biosite and Dnaform. The company is headquartered at San Francisco in California, the US.

Five Prime Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals and Healthcare eTrack deals database, and primary and secondary research.

Scope

  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

  • The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

  • The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

  • Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

  • The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

  • Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

  • Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

  • Five Prime Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012
  • Five Prime Therapeutics, Inc., Pharmaceuticals & Healthcare Deals By Type, 2006 to YTD 2012
  • Five Prime Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2006 to YTD 2012
  • Five Prime Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2006 to YTD 2012
  • Five Prime Therapeutics, Inc., Pharmaceuticals & Healthcare, Partnerships, Deals By Year Vs Deal Value Vs Upfront Payment, 2006 to YTD 2012
  • Five Prime Therapeutics, Inc., Pharmaceuticals & Healthcare, Partnerships, Deals By Therapy Area Vs Deal Value Vs Upfront Payment, 2006 to YTD 2012
  • Five Prime Therapeutics, Inc., Pharmaceuticals & Healthcare, Licensing Deals, Deals By Year Vs Deal Value Vs Upfront Payment, 2006 to YTD 2012
  • Five Prime Therapeutics, Inc., Pharmaceuticals & Healthcare, Licensing Deals, Deals By Therapy Area Vs Deal Value Vs Upfront Payment, 2006 to YTD 2012
  • Five Prime Therapeutics, Inc., Pharmaceuticals & Healthcare, Licensing Deals, Deals By Phase Vs Deal Value Vs Upfront Payment, 2006 to YTD 2012
  • Five Prime Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2006 to YTD 2012
  • Five Prime Therapeutics, Inc., Pharmaceuticals & Healthcare, Deal Details
  • Venture Financing
  • Five Prime Therapeutics Secures $7.5 Million In Venture Financing
  • FivePrime Therapeutics Raises $40.28 Million In Venture Financing
  • Five Prime Therapeutics Secures Venture Financing
  • FivePrime Therapeutics Raises $11 Million In Venture Financing
  • Partnerships
  • GlaxoSmithKline Expands Co-Development Agreement With Five Prime Therapeutics
  • Dyax Enters Into Research Agreement With Five Prime Therapeutics
  • Five Prime Therapeutics Enters Into Drug Discovery Agreement With GlaxoSmithKline
  • Five Prime Therapeutics Enters Into Co-Development Agreement With Fast Forward
  • Pfizer Enters Into An Agreement With FivePrime
  • FivePrime Enters Into Co-Development Agreement With Centocor
  • FivePrime Therapeutics Enters Into Research Agreement With Boehringer Ingelheim
  • Licensing Agreements
  • Human Genome Sciences Enters Into Licensing Agreement With FivePrime Therapeutics For FP-1039
  • Five Prime Therapeutics, Inc. - Key Competitors
  • Locations And Subsidiaries
  • Head Office
  • Recent Developments
    • Strategy And Business Planning
    • Aug 03, 2010: Five Prime Partners With GSK To Discover Innovative Biologics For Skeletal Muscle Disorders
    • Research And Development
    • Jun 16, 2011: Five Prime Therapeutics Provides Update On Strategic Discovery Collaborations With Pfizer And GlaxoSmithKline
    • May 25, 2010: Five Prime Partners With Fast Forward To Speed New Treatments To People With Multiple Sclerosis
    • Feb 24, 2010: Five Prime Receives Milestone Payment From Centocor For Therapeutic Program
    • Corporate Communications
    • Feb 06, 2012: Five Prime Therapeutics Confirms Appointment Of Lewis Williams As CEO
    • Oct 19, 2010: Five Prime Therapeutics Relocates To South San Francisco
    • Sep 27, 2010: Five Prime Therapeutics Elects Franklin Berger To Board
    • Oct 15, 2009: Five Prime Announces Senior Management Changes
    • Oct 15, 2009: Five Prime Therapeutics Announces Senior Management Changes
    • Jun 09, 2009: FivePrime Appoints Julia Gregory As CEO And Member Of Board Of Directors
    • Product News
    • Sep 21, 2010: Five Prime Receives Patents In US And Europe Covering Its Lead Oncology Drug
    • Sep 08, 2008: Five Prime Initiates Phase 1 Clinical Trials Of Fp-1039 In Patients With Advanced Cancers
    • Apr 29, 2010: Five Prime Therapeutics, Inc. To Present At Upcoming Bio International Convention
    • Mar 02, 2010: Five Prime Therapeutics, Inc. To Present At Upcoming Investor Conferences
    • Clinical Trials
    • Sep 08, 2008: FivePrime Initiates Phase 1 Clinical Trials Of FP-1039 In Patients With Advanced Cancers
  • Appendix
  • Methodology
  • About GlobalData
  • Contact Us
  • Disclaimer 42
  • List of Tables
    • Five Prime Therapeutics, Inc., Pharmaceuticals & Healthcare, Key Facts
    • Five Prime Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012
    • Five Prime Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2006 to YTD 2012
    • Five Prime Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2006 to YTD 2012
    • Five Prime Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012
    • Five Prime Therapeutics, Inc., Pharmaceuticals & Healthcare Deals By Type, 2006 to YTD 2012
    • Five Prime Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2006 to YTD 2012
    • Five Prime Therapeutics, Inc., Deals By Therapy Area, 2006 to YTD 2012
    • Five Prime Therapeutics, Inc., Pharmaceuticals & Healthcare, Partnerships, Deals By Year Vs Deal Value Vs Upfront Payment, 2006 to YTD 2012
    • Five Prime Therapeutics, Inc., Pharmaceuticals & Healthcare, Partnerships, Deals By Year Vs Deal Value Vs Upfront Payment, 2006 to YTD 2012
    • Five Prime Therapeutics, Inc., Pharmaceuticals & Healthcare, Partnerships, Deals By Therapy Area Vs Deal Value Vs Upfront Payment, 2006 to YTD 2012
    • Five Prime Therapeutics, Inc., Pharmaceuticals & Healthcare, Partnerships, Deals By Therapy Vs Deal Value Vs Upfront Payment, 2006 to YTD 2012
    • Five Prime Therapeutics, Inc., Pharmaceuticals & Healthcare, Licensing Deals, Deals By Year Vs Deal Value Vs Upfront Payment, 2006 to YTD 2012
    • Five Prime Therapeutics, Inc., Pharmaceuticals & Healthcare, Licensing Deals, Deals By Year Vs Deal Value Vs Upfront Payment, 2006 to YTD 2012
    • Five Prime Therapeutics, Inc., Pharmaceuticals & Healthcare, Licensing Deals, Deals By Therapy Area Vs Deal Value Vs Upfront Payment, 2006 to YTD 2012
    • Five Prime Therapeutics, Inc., Pharmaceuticals & Healthcare, Licensing Deals, Deals By Therapy Area Vs Deal Value Vs Upfront Payment, 2006 to YTD 2012
    • Five Prime Therapeutics, Inc., Pharmaceuticals & Healthcare, Licensing Deals, Deals By Phase Vs Deal Value Vs Upfront Payment, 2006 to YTD 2012
    • Five Prime Therapeutics, Inc., Pharmaceuticals & Healthcare, Licensing Deals, Deals By Phase Vs Deal Value Vs Upfront Payment, 2006 to YTD 2012
    • Five Prime Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2006 to YTD 2012
    • Five Prime Therapeutics Secures $7.5 Million In Venture Financing
    • FivePrime Therapeutics Raises $40.28 Million In Venture Financing
    • Five Prime Therapeutics Secures Venture Financing
    • FivePrime Therapeutics Raises $11 Million In Venture Financing
    • GlaxoSmithKline Expands Co-Development Agreement With Five Prime Therapeutics
    • Dyax Enters Into Research Agreement With Five Prime Therapeutics
    • Five Prime Therapeutics Enters Into Drug Discovery Agreement With GlaxoSmithKline
    • Five Prime Therapeutics Enters Into Co-Development Agreement With Fast Forward
    • Pfizer Enters Into An Agreement With FivePrime
    • FivePrime Enters Into Co-Development Agreement With Centocor
    • FivePrime Therapeutics Enters Into Research Agreement With Boehringer Ingelheim
    • Human Genome Sciences Enters Into Licensing Agreement With FivePrime Therapeutics For FP-1039
    • Five Prime Therapeutics, Inc., Key Competitors 33
  • List of Figures
    • Five Prime Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2006 to YTD 2012
    • Five Prime Therapeutics, Inc., Pharmaceuticals & Healthcare, Licensing Deals by Year, 2006 to YTD 2012
    • Five Prime Therapeutics, Inc., Pharmaceuticals & Healthcare, Licensing Deals by Phase, 2006 to YTD 2012
    • Five Prime Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012
    • Five Prime Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2006 to YTD 2012
    • Five Prime Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2006 to YTD 2012
    • Five Prime Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2006 to YTD 2012
+44 20 8816 8548

Ask a question about Five Prime Therapeutics, Inc. - Pharmaceuticals & Healthcare

Enter the characters you see in the picture below
Captcha